The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis-Reference-Cited by-同舟云学术

The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis

Published:2019-09 Issue:38 Volume:294 Page:14081-14095
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Singh Siddharth,Kumar Manoj^ORCID,Kumar Sanjeev,Sen Shrinka,Upadhyay Pawan,Bhattacharjee Sayan,M Naveen,Tomar Vivek Singh,Roy Siddhartha,Dutt Amit^ORCID,Kundu Tapas K.

Funder

Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Department of Biotechnology (DBT), Government of India

Department of Science and Technology (DST) Government of India

Life Science Education and Training at JNCASR

Jawaharlal Nehru Centre for Advanced Scientific Research

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference54 articles.

1. Transcriptional regulation by p53;Beckerman;Cold Spring Harb. Perspect. Biol,2010

2. The p53 protein is an unusually shaped tetramer that binds directly to DNA;Friedman;Proc. Natl. Acad. Sci. U.S.A,1993

3. How p53 binds DNA as a tetramer;McLure;EMBO J,1998

4. Cooperative binding of tetrameric p53 to DNA;Weinberg;J. Mol. Biol,2004

5. Requirement for p53 and p21 to sustain G2 arrest after DNA damage;Bunz;Science,1998

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment;Frontiers in Pharmacology;2024-08-05

2. KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways;Cells;2024-07-19

3. Genetic alterations in CDKN2A interacting network and their putative association with head and neck squamous cell carcinoma;Human Gene;2024-05

4. Computational approaches for identifying disease-causing mutations in proteins;Advances in Protein Chemistry and Structural Biology;2023

5. Emerging epigenetic therapies—lysine acetyltransferase inhibitors;Epigenetic Cancer Therapy;2023